November 3, 2025 November 3, 2025Categories New TrialsNow Enrolling: The EAA241 research study is exploring a new treatment approach for patients with newly diagnosed myeloma and kidney failureThis clinical trial aims to improve results with a set of medicines that will treat myeloma and reverse kidney failure at the same time
July 24, 2025 July 24, 2025Categories New TrialsNow Enrolling: The CLEAR research study is testing a new treatment combination for patients with operable non-small cell lung cancerThis clinical trial aims to improve treatment for high-risk patients by adding a targeted therapy to standard post-surgery immunotherapy
January 5, 2023 January 5, 2023Categories Ongoing TrialsOngoing Trial: The INSIGNA clinical trial is testing the timing of immunotherapy alone or with chemotherapy for patients with advanced lung cancerThis trial is seeking to find out whether patients with the PD-L1 biomarker can either delay having chemotherapy or avoid it altogether
December 15, 2021 December 15, 2021Categories New TrialsNow Enrolling: The OPTIMUM clinical trial is studying an additional treatment for patients with multiple myelomaThis trial is for patients who have cancer cells still in the blood or bone marrow after approximately one year of lenalidomide maintenance therapy following a stem cell transplant